Impact of Maternal Medication Use During Pregnancy on Childhood Cancer Risk: A Comprehensive Review and Meta-Analysis - Top-Institutions - MDSpire

Impact of Maternal Medication Use During Pregnancy on Childhood Cancer Risk: A Comprehensive Review and Meta-Analysis

  • By

  • Alicia Lübtow

  • Manuela Marron

  • Rajini Nagrani

  • Loviisa Mulanje

  • Wolfgang Ahrens

  • Lara Kim Brackmann

  • November 21, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Oncology
    • Cancer Epidemiology

  • #2

    Dana-Farber Cancer Institute / Boston Children's Hospital
    Dana-Farber Cancer Institute / Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Epidemiology

  • #3

    National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics
    National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics

    Bethesda, MD

    Key Differentiators

    • Cancer Epidemiology
    • Genetic Epidemiology

  • #4

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Pediatric Oncology
    • Perinatal Epidemiology

  • #5

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Oncology
    • Clinical Epidemiology

Original Source(s)

Impact of Maternal Medication Use During Pregnancy on Childhood Cancer Risk: A Comprehensive Review and Meta-Analysis

  • by Alicia Lübtow, Manuela Marron, Rajini Nagrani, Loviisa Mulanje, Wolfgang Ahrens, Lara Kim Brackmann

  • November 21, 2025

Related Content

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

Armoring CAR-T Against Solid Tumors

UCLA researchers create armored CAR-T cells that show promise for treating solid tumors

  • March 17, 2026

  • 3 min
Silencing TMED2 suppresses cell growth and tumor progression in diffuse large B-cell lymphoma via inducing G0/G1 cell cycle arrest